Embryonic stem cell trials for macular degeneration: a preliminary report
SDSteven D. SchwartzJHJean‐Pierre HubschmanGHGad HeilwellVFValentina Franco-CardenasCKCarolyn K. Pan
Doheny Eye Institute · University of California, Los Angeles · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,410
total citations
- FWCI
- 85.45
- Percentile
- 100%
- References
- 36
Citations per year
Authors
10- SDSteven D. SchwartzCorresponding
Doheny Eye Institute, University of California, Los Angeles
- JHJean‐Pierre Hubschman
University of California, Los Angeles, Doheny Eye Institute
- GHGad Heilwell
Doheny Eye Institute, University of California, Los Angeles
- VFValentina Franco-Cardenas
Doheny Eye Institute, University of California, Los Angeles
- CKCarolyn K. Pan
Doheny Eye Institute, University of California, Los Angeles
Topics & keywords
Topics
Keywords
- Macular degeneration
- Retinal pigment epithelium
- Medicine
- Visual acuity
- Transplantation
- Ophthalmology
- Tolerability
- Clinical trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.